1. Molnupiravir Is Next
In the next five weeks or so, kids 5 and over will be able to get a vaccine for COVID.
Today we have news that Merck’s antiviral pill, Molnupiravir, is moving forward to seek approval from the FDA.
Initial studies suggest that Molnupiravir—Worst. Branding. Ever.—will reduce hospitalizations and deaths among symptomatic…